CT Findings From Interstitial Lung Diseases in Patients With Metastatic Breast Cancer Treated With Fam-Trastuzumab Deruxtecan: A Single Institutional Experience

This single-institute, retrospective cohort study enrolled patients with human epidermal growth factor receptor 2-positive metastatic breast cancer treated with trastuzumab deruxtecan between August 2017 and January 2021 from four previous studies. Of 31 patients, 4 (12.9%) had interstitial lung dis...

Descripción completa

Detalles Bibliográficos
Autores principales: Jang, Yoon Jung, Jeong, Jae Ho, Kim, Jeong Eun, Ahn, Jin-Hee, Jung, Kyung Hae, Kim, Sung-Bae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Breast Cancer Society 2021
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876542/
https://www.ncbi.nlm.nih.gov/pubmed/35133090
http://dx.doi.org/10.4048/jbc.2022.25.e1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876542/
https://www.ncbi.nlm.nih.gov/pubmed/35133090
http://dx.doi.org/10.4048/jbc.2022.25.e1

Ejemplares similares